Morning Briefing
Summaries of health policy coverage from major news organizations
FDA, Pharmaceutical Industry Reach Agreement On User-Fee Plan For Generics
The Washington Post reports that the deal could result in the collection of hundreds of millions of dollars in new fees from drug companies to speed the review of generics.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
